The biggest new product, torcetrapib, failed only a day after Kindler told journalists at a big rah-rah meeting that this was Pfizer's new wonder-drug.
Major layoffs have resulted in rock-bottom morale among the sales force and plant closings has resulted in the firing of the scientist who developed Lipitor, Pfizer's $13 billion-drug.
So what did Jeff decide to do?
He realized he needed to put some lipstick on that pig and for the first time in Pfizer history hire a spin-doctor who will report directly to the CEO.
Pfizer Inc named Sally Susman Senior Vice President of Worldwide Communications and Chief Communications Officer with overall responsibility for Pfizer's global communications, reporting to Chairman and Chief Executive Officer Jeff Kindler. She will join Pfizer's Executive Leadership Team.
Ms. Susman has an interesting background.
No pharma experience; she was a communications executive at The Estee Lauder Companies Inc., where she directed the communications strategy for the global public Corporation and each of its 28 brands. Lipsticks, mascara, and such, we presume.
Kind of interesting that the largest drug company in the world now has two decidedly non-scientific people running the show.
The hambuger-man teams up with a cosmetics girl.